Here, we show that MEK5 or Cdc37 overexpression—two mechanisms that induce nuclear ERK5—results in ERK5 SUMOylation at residues Lys6 and Lys22 in cancer cells (Figure 1). This evidence concerns the gene MAP2K5 and cancer.